Because Helicobacter pylori is an acid-sensitive organism, an elevatio
n of the gastric pH by H-2 inhibitors might improve the intragastric c
onditions for the development of this organism. We tested this hypothe
sis in a prospective and controlled trial including 43 patients positi
ve for H. pylori using the rapid urease test. Twenty-six patients rece
ived 150 mg ranitidine twice daily and 17 patients received no treatme
nt. The C-14-urea breath test was performed in both groups at the begi
nning of the study and 2 weeks later. Radioactive C-14 in exhaled carb
on dioxide was significantly increased (p = 0.045) in the patients tre
ated with ranitidine, compared with the patients in the control group.
Administration of this drug to patients infected with H. pylori is as
sociated with an increase in the bacterial load after 2 weeks of treat
ment. This phenomenon might be attributed to increased bacterial growt
h due to the H-2 blocker.